Cyclin-Dependent Kinases
Cyclin-Dependent Kinases(细胞周期蛋白依赖性激酶)
Cyclin-dependent kinases is a group of serine/threonine kinases. It is activated by binding to cyclin and participates in the regulation of cell cycle.
Cyclin-Dependent Kinases 相关产品(69)
- GC11401Roscovitine (Seliciclib,CYC202)CAS: 186692-46-6纯度: >98.50% / >98.00%
Roscovitine (Seliciclib,CYC202)是一种有效的Cdk2/cyclin E抑制剂,IC 50 值为0.1μM。Roscovitine还抑制Cdk7/cyclin H、Cdk5/p35以及(cdc)/cyclin B,IC 50 值分别为0.49、0.16和0.65μM。
- GC11823LY2835219 free baseCAS: 1231929-97-7纯度: >99.50% / >97.00% / >99.00%
LY2835219 free base是 CDK4 和 CDK6 的强效选择性抑制剂,在非细胞实验中的 IC 50 分别为 2nM 和 10nM。
- GC12425CDK inhibitor IICAS: 1269815-17-9纯度: >98.50%
CDK inhibitor II 是一种有效且特异性的 CDK9 抑制剂,IC50 <8 nM,取自参考文献 1,实施例 4。
- GC12871CDK9 inhibitorCAS: 1415559-43-1纯度: >98.50%
CDK9 inhibitor 是一种新型的选择性 CDK9 抑制剂,用于治疗 HIV 感染,对 CDK9/CycT1 的 IC50 为 39 nM,从参考化合物 87 中提取。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10840 | THZ1 | 1604810-83-4 | >98.50% | |
A covalent Cdk7 inhibitor | ||||
| GC10842 | LEE011 | 1211441-98-3 | >99.50% | |
LEE011是一种具有口服活性的特异性细胞周期蛋白依赖性激酶CDK4/6抑制剂。LEE011以纳摩尔浓度靶向cyclin D1/CDK4和cyclin D3/CDK6。 | ||||
| GC12438 | AZD-5438 | 602306-29-6 | >99.50% | |
A potent inhibitor of CDKs | ||||
| GC17648 | Dinaciclib(SCH727965) | 779353-01-4 | >98.00% | |
A CDK inhibitor | ||||
| GC11396 | SNS-032 (BMS-387032) | 345627-80-7 | >99.00% | |
A Cdk2, Cdk7, and Cdk9 inhibitor | ||||
| GC11401 | Roscovitine (Seliciclib,CYC202) | 186692-46-6 | >98.50% / >98.00% | |
Roscovitine (Seliciclib,CYC202)是一种有效的Cdk2/cyclin E抑制剂,IC 50 值为0.1μM。Roscovitine还抑制Cdk7/cyclin H、Cdk5/p35以及(cdc)/cyclin B,IC 50 值分别为0.49、0.16和0.65μM。 | ||||
| GC11410 | Aminopurvalanol A | 220792-57-4 | - | |
A selective CDK inhibitor | ||||
| GC11564 | Cdk4/6 Inhibitor IV | 359886-84-3 | - | |
A cell-permeable inhibitor of Cdk4/6 | ||||
| GC11634 | NSC 693868 | 40254-90-8 | - | |
A selective inhibitor of Cdk1 and Cdk5 | ||||
| GC11785 | CDK4 inhibitor | 1256963-02-6 | - | |
An antiproliferative cyclin D1/Cdk4 inhibitor | ||||
| GC11823 | LY2835219 free base | 1231929-97-7 | >99.50% / >97.00% / >99.00% | |
LY2835219 free base是 CDK4 和 CDK6 的强效选择性抑制剂,在非细胞实验中的 IC 50 分别为 2nM 和 10nM。 | ||||
| GC11835 | Deferasirox | 201530-41-8 | >99.50% | |
Deferasirox是一种具口服活性的铁螯合剂,用于治疗铁过载疾病。 | ||||
| GC11944 | PF 4800567 hydrochloride | 1391052-28-0 | - | |
A selective CK1ε inhibitor | ||||
| GC11971 | LY2857785 | 1619903-54-6 | >98.50% | |
A Cdk9 inhibitor | ||||
| GC12001 | BS-181 | 1092443-52-1 | - | |
A selective Cdk7 inhibitor | ||||
| GC12064 | SB1317 | 937270-47-8 | >99.50% | |
A multi-kinase inhibitor | ||||
| GC12348 | Ro 3306 | 872573-93-8 | >98.00% | |
Ro 3306是一种ATP竞争性抑制剂,主要靶向CDK1/cyclin B1(K i 值为35nmol/L)和CDK1/cyclin A复合物(K i 值为110nmol/L)。 | ||||
| GC12425 | CDK inhibitor II | 1269815-17-9 | >98.50% | |
CDK inhibitor II 是一种有效且特异性的 CDK9 抑制剂,IC50 <8 nM,取自参考文献 1,实施例 4。 | ||||
| GC12826 | AZD-5597 | 924641-59-8 | - | |
Potent CDK inhibitor | ||||
| GC12865 | BMS265246 | 582315-72-8 | >99.00% | |
A cell-permeable inhibitor of Cdk1 and Cdk2 | ||||
| GC12871 | CDK9 inhibitor | 1415559-43-1 | >98.50% | |
CDK9 inhibitor 是一种新型的选择性 CDK9 抑制剂,用于治疗 HIV 感染,对 CDK9/CycT1 的 IC50 为 39 nM,从参考化合物 87 中提取。 | ||||
| GC12886 | NSC 625987 | 141992-47-4 | - | |
A Cdk4/cyclin D1 complex inhibitor | ||||
| GC13100 | [Ala92]-p16 (84-103) | 189064-08-2 | - | |
inhibitor of cyclin-dependent kinase-4 (cdk4)/cyclin D1 | ||||
| GC13511 | THZ2 | 1604810-84-5 | >99.50% | |
A Cdk7 inhibitor | ||||
